Balaxi Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 863.85 million compared to INR 702.3 million a year ago. Revenue was INR 905.23 million compared to INR 703.63 million a year ago. Net income was INR 154.87 million compared to INR 120.54 million a year ago. Basic earnings per share from continuing operations was INR 15.49 compared to INR 12.05 a year ago. Diluted earnings per share from continuing operations was INR 15.49 compared to INR 12.05 a year ago.
For the six months, sales was INR 1,691.7 million compared to INR 1,285.65 million a year ago. Revenue was INR 1,765.92 million compared to INR 1,298.71 million a year ago. Net income was INR 296.33 million compared to INR 227.68 million a year ago. Basic earnings per share from continuing operations was INR 29.63 compared to INR 22.77 a year ago. Diluted earnings per share from continuing operations was INR 29.63 compared to INR 22.77 a year ago.